News

heart data AI algorithm cardiologist doctor

FDA clears next-generation cardiac mapping software

San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

Noteworthy AI news: Prez Trump vs. state regulators, HHS’s AI strategy 1 week out, imperfect AI, more

State-level regulation of AI: President Trump has turned his thinking into action.

Arnold Seto, MD, MPA, FACC, FSCAI, cath lab director, Long Beach VA Medical Center, professor of medicine at Charles Drew University, Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and chair of the SCAI Advocacy Committee, explains changes in payment policy are making ambulatory surgical centers (ASC) and office based labs (OBL) more attractive to both cardiologists and larger health systems.

More interventional procedures may be coming to an ambulatory surgical center near you

ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.

New recalls announced for troubled heart devices—FDA previously urged customers to seek alternatives

Back in 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options. These most recent recalls focus on a series of maintenance issues that have already been addressed.

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

Lawsuit claims clinic used AI to record patient conversations without consent

According to attorneys representing a potential class action of plaintiffs, Sharp HealthCare was not forthcoming about its use of a tool for automatic note-taking. The technology allegedly captures everything said in an exam room, including sensitive details on diagnoses, and sends it to an offsite server.

White House executive order aims to curb ‘excessive’ state regulation of AI

President Donald Trump wants to establish an AI Litigation Task Force to challenge any AI laws that may “harm innovation.”

Lumexa Imaging raises nearly $463M from successful IPO

“Going public is not a finish line. It’s the beginning of our next chapter,” CEO Caitlin Zulla, MPH, said in prepared remarks Dec. 11.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

In-house radiology 3D printing could produce significant savings.

In-house radiology 3D printing could slash costs by up to 70% per model

A 3D printer investment could "pay for itself after just a few prints,” new data suggest.

AI's biggest return on investment currently comes in the form of time

Artificial Intelligence offers organizations value that extends beyond just payments, new survey data suggest.

CPT code updates in 2026 will change how interventional cardiologists get paid

A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.

Around the web

Cardiovascular Business